
-

Cannabinoid Shown Safe, Lowers Agitation in Alzheimer’s Patients
A clinical trial in a small group of participants suggests a cannabinoid drug is safe and well-tolerated, and reduces agitation among patients with Alzheimer’s disease.
-

Start-Up Developing Precision Antibiotics for Resistant Bacteria
A company formed earlier this year is developing precision treatments for bacteria resistant to conventional antibiotics, and raising £4.3 million ($US 5.4 million) in seed funds.
-

Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds
A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round.
-

Infographic – Digital Health Funding Continues Slide
Venture funding for digital health start-ups continued heading down in the third quarter of 2023, reaching low levels not seen in almost a decade.
-

Peanut Allergy Toothpaste Shown Safe in Trial
Results of a clinical trial show a peanut allergy treatment formulated as a toothpaste can safely deliver immunotherapy to raise recipients’ peanut tolerance.
-

Challenge Seeks Transformative Human/A.I. Research Tech
A new challenge competition with $1 million in prizes seeks novel techniques for conducting biomedical research with data on human physiology and artificial intelligence.
-

Life Science Incubator Gains $100M in Start-Up Funds
A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant.
-

Home V.R. Therapy Shown to Reduce Back Pain
A virtual reality program conducted at home is shown in a clinical trial to relieve chronic lower back pain intensity and improve daily living more than a sham V.R. program.
-

Electric Pulses Induce Lung Cancer Immune Response
Results of a clinical trial show a lung cancer therapy using highly focused pulses with electrical energy show signs of immune responses that can treat the patients’ tumors.
-
Keeping Conversations Positive with Precision Moderation
Sponsored content removed due to non-payment.